Pacer Advisors’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $515K | Sell |
9,864
-4,683
| -32% | -$281K | ﹤0.01% | 1480 |
|
|
2025
Q4 | $856K | Sell |
14,547
-15,901
| -52% | -$966K | ﹤0.01% | 1543 |
|
|
2025
Q3 | $1.69M | Buy |
30,448
+14,696
| +93% | +$787K | ﹤0.01% | 1166 |
|
|
2025
Q2 | $810K | Buy |
15,752
+7,632
| +94% | +$383K | ﹤0.01% | 1308 |
|
|
2025
Q1 | $476K | Sell |
8,120
-4,635
| -36% | -$314K | ﹤0.01% | 1473 |
|
|
2024
Q4 | $919K | Sell |
12,755
-2,957
| -19% | -$217K | ﹤0.01% | 1400 |
|
|
2024
Q3 | $1.26M | Buy |
15,712
+572
| +4% | +$43K | ﹤0.01% | 1226 |
|
|
2024
Q2 | $1.08M | Buy |
15,140
+4,488
| +42% | +$330K | ﹤0.01% | 1248 |
|
|
2024
Q1 | $750K | Sell |
10,652
-1,645
| -13% | -$118K | ﹤0.01% | 1379 |
|
|
2023
Q4 | $949K | Sell |
12,297
-11,302
| -48% | -$744K | ﹤0.01% | 1220 |
|
|
2023
Q3 | $1.61M | Buy |
23,599
+5,805
| +33% | +$459K | 0.01% | 658 |
|
|
2023
Q2 | $1.45M | Buy |
17,794
+5,606
| +46% | +$451K | 0.01% | 872 |
|
|
2023
Q1 | $904K | Buy |
12,188
+11,535
| +1,766% | +$889K | ﹤0.01% | 980 |
|
|
2022
Q4 | $54.1K | Sell |
653
-6,523
| -91% | -$518K | ﹤0.01% | 2837 |
|
|
2022
Q3 | $509K | Sell |
7,176
-84
| -1% | -$7.26K | ﹤0.01% | 772 |
|
|
2022
Q2 | $629K | Sell |
7,260
-60,192
| -89% | -$5.64M | ﹤0.01% | 638 |
|
|
2022
Q1 | $7.3M | Buy |
67,452
+32,240
| +92% | +$3.33M | 0.06% | 330 |
|
|
2021
Q4 | $4.55M | Buy |
35,212
+24,676
| +234% | +$3.03M | 0.05% | 493 |
|
|
2021
Q3 | $1.28M | Sell |
10,536
-5,844
| -36% | -$711K | 0.02% | 791 |
|
|
2021
Q2 | $1.84M | Sell |
16,380
-192
| -1% | -$20.2K | 0.03% | 634 |
|
|
2021
Q1 | $1.58M | Buy |
16,572
+588
| +4% | +$53.6K | 0.03% | 586 |
|
|
2020
Q4 | $1.27M | Sell |
15,984
-19,572
| -55% | -$1.42M | 0.02% | 600 |
|
|
2020
Q3 | $2.2M | Buy |
+35,556
| New | +$2.31M | 0.05% | 384 |
|
|
2020
Q1 | – | Sell |
-51,840
| Closed | -$2.85M | – | 1074 |
|
|
2019
Q4 | $2.85M | Sell |
51,840
-3,968
| -7% | -$208K | 0.13% | 165 |
|
|
2019
Q3 | $2.73M | Sell |
55,808
-4,320
| -7% | -$217K | 0.06% | 361 |
|
|
2019
Q2 | $3.13M | Buy |
+60,128
| New | +$3.03M | 0.08% | 301 |
|
|
2018
Q4 | – | Sell |
-54,632
| Closed | -$2.79M | – | 988 |
|
|
2018
Q3 | $2.79M | Buy |
54,632
+7,096
| +15% | +$314K | 0.1% | 199 |
|
|
2018
Q2 | $1.76M | Buy |
47,536
+6,848
| +17% | +$261K | 0.08% | 332 |
|
|
2018
Q1 | $1.54M | Buy |
40,688
+4,592
| +13% | +$162K | 0.09% | 293 |
|
|
2017
Q4 | $1.17M | Buy |
36,096
+16,712
| +86% | +$531K | 0.08% | 346 |
|
|
2017
Q3 | $586K | Buy |
19,384
+2,000
| +12% | +$59.4K | 0.05% | 583 |
|
|
2017
Q2 | $511K | Buy |
17,384
+700
| +4% | +$19.1K | 0.05% | 592 |
|
|
2017
Q1 | $424K | Buy |
16,684
+3,060
| +22% | +$79K | 0.05% | 590 |
|
|
2016
Q4 | $350K | Buy |
13,624
+628
| +5% | +$16.5K | 0.05% | 591 |
|
|
2016
Q3 | $356K | Buy |
12,996
+1,516
| +13% | +$41.6K | 0.05% | 516 |
|
|
2016
Q2 | $324K | Buy |
+11,480
| New | +$295K | 0.05% | 533 |
|
Other funds holding TECH
VCM
VPM
MC
Pacer Advisors's TECH Position: Q1 2026 in Review
Pacer Advisors reduced its Bio-Techne (TECH) stake by 32% in Q1 2026, selling an estimated $281K and leaving 9,864 shares worth $515K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.
Pacer Advisors first reported a position in TECH in Q2 2016 and has held it in 36 quarters since. The position peaked at $7.3M in Q1 2022. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Pacer Advisors held 9,864 shares of Bio-Techne worth $515K as of Q1 2026.
- Pacer Advisors sold 4,683 Bio-Techne shares in Q1 2026, an estimated $281K.
- Bio-Techne made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1480 holding.
- Pacer Advisors first reported a position in Bio-Techne in Q2 2016 and has held it in 36 quarters since.
- Pacer Advisors's Bio-Techne position peaked at $7.3M in Q1 2022.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.